Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure

This publication has 48 references indexed in Scilit:

• Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
  Genetics in Medicine, 2018
• “Not pathogenic until proven otherwise”: perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project
  Genetics in Medicine, 2018
• Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
  JNCI: Journal of the National Cancer Institute, 2017
• Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies
  Genetics in Medicine, 2017
• Genetic identification of familial hypercholesterolemia within a single U.S. health care system
  Science, 2016
• The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists
  Journal of Medical Genetics, 2015
• The cost-effectiveness of returning incidental findings from next-generation genomic sequencing
  Genetics in Medicine, 2014
• Precision Medicine Meets Public Health: Population Screening for BRCA1 and BRCA2
  JNCI: Journal of the National Cancer Institute, 2014
• ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
  Genetics in Medicine, 2013
• Whole-genome sequencing in health care
  European Journal of Human Genetics, 2013